This announcement is a separate document:
昂利康:东方证券承销保荐有限公司关于浙江昂利康制药股份有限公司调整2020年非公开发行股票募集资金投资项目部分实施内容的核查意见
Onlikang: Orient Securities Underwriting and Sponsorship Co., Ltd.'s inspection opinions on Zhejiang Anglikang Pharmaceutical Co., Ltd.'s adjustments to some of the implementation details of the 2020 non-public stock raising capital investment project
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.